Sana Biotechnology Inc.

NASDAQ: SANA · Real-Time Price · USD
3.33
-0.10 (-2.92%)
At close: Aug 15, 2025, 3:59 PM
3.36
0.75%
After-hours: Aug 15, 2025, 07:52 PM EDT

Sana Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-252.18M -208.67M -266.76M -305.81M -244.9M -308.61M -283.25M -275.58M -361.69M -320.15M -269.48M -299.76M -297.91M -206.76M -355.93M -358.37M -326.56M -433.05M
Depreciation & Amortization
16.26M 17.29M 17.39M 19.24M 19.68M 20.23M 20.83M 17.49M 17M 16.36M 15.63M 14.77M 13.63M 12.44M 11.07M 9.49M 8.13M 6.9M
Stock-Based Compensation
30.86M 35.61M 37.68M 39.17M 37.41M 35.87M 35.53M 38.19M 39.27M 39.33M 38.34M 35.06M 30.93M 25.96M 22.36M 17.84M 13.06M 9.23M
Other Working Capital
-9.07M -2.8M -2.56M 7.03M 9.77M 21.64M 17.58M 1.5M 9.19M 1.31M 6.48M 11.11M 4.42M 9.52M 10.07M 13.04M 13.93M 2.92M
Other Non-Cash Items
34.63M -27.32M 25.87M 75.16M -1.68M 32.6M -20.96M -60.57M 16.8M -27.25M -82.08M -85.73M -61.61M -120.06M 61.64M 146.07M 133.7M 261.98M
Deferred Income Tax
n/a n/a n/a -24.35M -24.35M -24.35M -24.35M n/a n/a n/a n/a n/a n/a n/a n/a -7.55M -7.55M -7.55M
Change in Working Capital
-10.3M -4.58M -1.19M 4.79M 10.31M 21.96M 18.61M 2.78M 9.68M 96K 7.54M 11.59M 5.18M 9.58M 9.8M 14M 13.68M 4.13M
Operating Cash Flow
-180.74M -206.18M -223.15M -227.95M -239.68M -239.94M -253.58M -277.69M -278.94M -291.61M -290.05M -324.08M -309.77M -278.85M -251.05M -178.51M -165.54M -158.35M
Capital Expenditures
-4.55M -17.72M -33.43M -47.04M -45.18M -33.7M -20.03M -10.59M -12.71M -15.52M -20.88M -21.48M -25.19M -30.95M -29.86M -33.93M -32.18M -24.71M
Cash Acquisitions
635K 253K n/a -29.36K -82.94K -127.14K -127.14K -97.78K -80.41K -118.33K -118.33K -118.33K -82.12K n/a n/a -3.19M -3.19M -3.19M
Purchase of Investments
-50.73M -113.35M -226.06M -239.12M -263.5M -251.71M -157.74M -146.72M -103.99M -73.44M -78.69M -140.53M -371.8M -472.25M -491.39M -494.47M -509.86M -432.24M
Sales Maturities Of Investments
167.79M 242.1M 276.95M 271.83M 303.92M 317.46M 349.79M 402.44M 342.34M 349.71M 310.13M 215.06M 232.27M 225.44M 280.02M 369.3M 300.54M 214.3M
Other Investing Acitivies
n/a n/a -61.38M -61.35M -61.3M -61.26M 127.14K 97.78K 80.41K 118.33K 20.2M 15.62M -162.25M -187.5M -152.05M -144.28M -228.44M -237.05M
Investing Cash Flow
113.15M 111.28M 17.45M -14.32M -4.75M 32.06M 172.01M 245.13M 225.64M 260.74M 210.56M 48.47M -169.29M -282.34M -245.8M -159.1M -241.5M -242.65M
Debt Repayment
-55K 31K 116K 172K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a -60K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
184.82M 195.83M 199.63M 17.93M 16.19M 7.61M 2.92M 4.1M 3.91M 1.42M 1.18M 3.12M 4.71M 5.05M 5.35M 2.23M 640K 435.88M
Financial Cash Flow
4.27M 14.33M 199.75M 200.82M 198.93M 217.81M 31.65M 30.99M 32.42M 4.5M 4.91M 6.97M 6.95M 5.7M 631.75M 628.74M 627.14M 1.06B
Net Cash Flow
-63.32M -80.56M -5.95M -41.45M -45.51M 9.92M -49.92M -1.57M -20.87M -26.37M -74.58M -268.64M -472.12M -555.49M 134.9M 291.13M 220.1M 661.39M
Free Cash Flow
-185.29M -223.9M -256.58M -274.99M -284.86M -273.64M -273.61M -288.28M -291.64M -307.13M -310.93M -345.56M -334.96M -309.81M -280.92M -212.44M -197.72M -183.06M